Jeffrey Lecheminant
Foot & Ankle Surgery · Yakima, WANPI 1124330493
Payments from drug & device makers
Across 40 payments — averaging $58.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Mimedx Group, Inc.$98
- GSK$97
- Stryker$78
- Sanofi-aventis U.S. LLC$73
- Lilly USA, LLC$57
- plus $352 from 14 others
What the payments were for
- Travel & lodging$1,35258%
- Food & beverage$99642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 10 | $1,594 |
| Mimedx Group, Inc. | 1 | $98 |
| GSK | 5 | $97 |
| Stryker | 3 | $78 |
| Sanofi-aventis U.S. LLC | 3 | $73 |
| Lilly USA, LLC | 3 | $57 |
| Invictus Surgical Incorporated | 1 | $44 |
| Inspire Medical Systems, Inc. | 1 | $42 |
| Biowound Solutions, Inc. | 1 | $42 |
| Amgen | 2 | $36 |
| Johnson & Johnson | 1 | $34 |
| AbbVie | 1 | $20 |
| Exact Sciences | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Heron Therapeutics, Inc. | 1 | $15 |
| QOL Medical, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,348 in reported general payments places this provider in the 55th percentile of 203 foot & ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 28 | $213 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $178 |
| Terbinafine Hcl | 17 | $148 |
| SsdSilver Sulfadiazine | 15 | $131 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Yakima
- Shyler DemillYakima$26K
- Jeffrey ChristensenEverett$884K
- David DalstromSeattle$497K
- Richard LamourOlympia$87K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Craig CliffordFederal Way$44K
- Shawn KhademiRenton$43K
- Gregory GrabowskiBellevue$34K
- Jacob McLeodLongview$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.